Cyclooxygenase

(Difference between revisions)

Revision as of 10:44, 7 December 2010

Table X: Selectivity of some NSAIDs
Drug	Coefficient of selectivity (IC50Cox-1/IC50Cox-2)
Ketorolac	100-1000
Naproxen	1-10
Ibuprofen	1-10
Indometacin	1-10
Acetylsalicylic acid	1
Diclofenac	1-0.1
Valdecoxib	0.01-0.001
Etoricoxib	0.01-0.001

Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16123-8. Epub 2006 Oct 23. PMID:17060607

Page seeded by OCA on Tue Feb 17 02:59:53 2009

Ghosh N, Chaki R, Mandal V, Mandal SC. COX-2 as a target for cancer chemotherapy. Pharmacol Rep. 2010 Mar-Apr;62(2):233-44. PMID:20508278

Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-82. PMID:10966456 doi:10.1146/annurev.biochem.69.1.145

Rang HP, Dale MM, Ritter JM, Flower RJ. 2008. Pharmacology. Elsevier. 6th edition. 844 p.

Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest. 2001 Jun;107(12):1491-5. PMID:11413152 doi:10.1172/JCI13271

Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31. Epub 2002 Sep 19. PMID:12242329 doi:10.1073/pnas.162468699

@@ Line 1: / Line 1: @@
-==Structure==
+<Structure load='5cox' size='500' frame='true' align='right' caption='Unhibited mouse cyclooxygenase' scene='Insert optional scene name here' />
-<Structure load='6cox' size='400' frame='true' align='right' scene='Insert optional scene name here' />
 ==NSAIDs==
 {| border="1" style="margin: 1em auto 1em auto;"